407 related articles for article (PubMed ID: 28667871)
21. Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):532-546. PubMed ID: 30688116
[TBL] [Abstract][Full Text] [Related]
22. Design, Synthesis and Screening of 4,6-Diaryl Pyridine and Pyrimidine Derivatives as Potential Cytotoxic Molecules.
Abd Elhameid MK; Ryad N; Al-Shorbagy MY; Mohammed MR; Ismail MM; El Meligie S
Chem Pharm Bull (Tokyo); 2018 Oct; 66(10):939-952. PubMed ID: 30111667
[TBL] [Abstract][Full Text] [Related]
23. Novel Pyrazoloquinolin-2-ones: Design, synthesis, docking studies, and biological evaluation as antiproliferative EGFR-TK inhibitors.
Elbastawesy MAI; Aly AA; Ramadan M; Elshaier YAMM; Youssif BGM; Brown AB; El-Din A Abuo-Rahma G
Bioorg Chem; 2019 Sep; 90():103045. PubMed ID: 31212178
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of β-lapachone-monastrol hybrids as potential anticancer agents.
Wu L; Ma X; Yang X; Zhang C
Eur J Med Chem; 2020 Oct; 203():112594. PubMed ID: 32682198
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
26. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
[TBL] [Abstract][Full Text] [Related]
27. Regioselective synthesis of novel 4,5-diaryl functionalized 3,4-dihydropyrimidine-2(1H)-thiones via a non-Biginelli-type approach and evaluation of their in vitro anticancer activity.
Sośnicki JG; Struk Ł; Kurzawski M; Perużyńska M; Maciejewska G; Droździk M
Org Biomol Chem; 2014 Jun; 12(21):3427-40. PubMed ID: 24752551
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation.
Marzouk AA; Abdel-Aziz SA; Abdelrahman KS; Wanas AS; Gouda AM; Youssif BGM; Abdel-Aziz M
Bioorg Chem; 2020 Sep; 102():104090. PubMed ID: 32683176
[TBL] [Abstract][Full Text] [Related]
29. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents.
Mochona B; Qi X; Euynni S; Sikazwi D; Mateeva N; Soliman KF
Bioorg Med Chem Lett; 2016 Jun; 26(12):2847-2851. PubMed ID: 27156770
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Baek D; Choi J; Lee H; Oh CH
J Enzyme Inhib Med Chem; 2016; 31(sup2):111-122. PubMed ID: 27255180
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents.
Verma G; Chashoo G; Ali A; Khan MF; Akhtar W; Ali I; Akhtar M; Alam MM; Shaquiquzzaman M
Bioorg Chem; 2018 Apr; 77():106-124. PubMed ID: 29353728
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel furo[2,3-d]pyrimidin-2-one-1,3,4-oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis.
El Mansouri AE; Oubella A; Dânoun K; Ahmad M; Neyts J; Jochmans D; Snoeck R; Andrei G; Morjani H; Zahouily M; Lazrek HB
Arch Pharm (Weinheim); 2021 Oct; 354(10):e2100146. PubMed ID: 34128255
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis, and Screening of 5-Aryl-3-(2-(pyrrolyl)thiophenyl)-1,2,4-oxadiazoles as Potential Antitumor Molecules on Breast Cancer MCF-7 Cell Line.
Abd El Hameid MK
Chem Pharm Bull (Tokyo); 2018 Dec; 66(12):1181-1195. PubMed ID: 30298827
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors.
Zeidan MA; Mostafa AS; Gomaa RM; Abou-Zeid LA; El-Mesery M; El-Sayed MA; Selim KB
Eur J Med Chem; 2019 Apr; 168():315-329. PubMed ID: 30826508
[TBL] [Abstract][Full Text] [Related]
36. Discovery of novel heteroarylmethylcarbamodithioates as potent anticancer agents: Synthesis, structure-activity relationship analysis and biological evaluation.
Li YB; Yan X; Li RD; Liu P; Sun SQ; Wang X; Cui JR; Zhou DM; Ge ZM; Li RT
Eur J Med Chem; 2016 Apr; 112():217-230. PubMed ID: 26900655
[TBL] [Abstract][Full Text] [Related]
37. Design and Synthesis of New CDK2 Inhibitors Containing Thiazolone and Thiazolthione Scafold with Apoptotic Activity.
El-Sattar NEAA; Badawy EHK; AbdEl-Hady WH; Abo-Alkasem MI; Mandour AA; Ismail NSM
Chem Pharm Bull (Tokyo); 2021; 69(1):106-117. PubMed ID: 33390512
[TBL] [Abstract][Full Text] [Related]
38. Facile synthesis and antiproliferative activity of 7H-benzo[7,8]chromeno[2,3-d]pyrimidin-8-amines.
Akrami H; Safavi M; Mirjalili BF; Dehghani Ashkezari M; Dadfar F; Mohaghegh N; Emami S; Salehi F; Nadri H; Ardestani SK; Firoozpour L; Khoobi M; Foroumadi A
Eur J Med Chem; 2017 Feb; 127():128-136. PubMed ID: 28039771
[TBL] [Abstract][Full Text] [Related]
39. New indenopyrazole linked oxadiazole conjugates as anti-pancreatic cancer agents: Design, synthesis, in silico studies including 3D-QSAR analysis.
Khan I; Ganapathi T; Rehman MM; Shareef MA; Kumar CG; Kamal A
Bioorg Med Chem Lett; 2021 Jul; 44():128094. PubMed ID: 33964437
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin.
Naaz F; Ahmad F; Lone BA; Pokharel YR; Fuloria NK; Fuloria S; Ravichandran M; Pattabhiraman L; Shafi S; Shahar Yar M
Bioorg Chem; 2020 Jan; 95():103519. PubMed ID: 31884140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
